➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
McKesson
McKinsey
AstraZeneca
Medtronic

Last Updated: June 6, 2020

DrugPatentWatch Database Preview

Quagen Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for QUAGEN, and what generic and branded alternatives to QUAGEN drugs are available?

QUAGEN has five approved drugs.



Summary for Quagen
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5

Drugs and US Patents for Quagen

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quagen PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040673-002 Mar 5, 2008 AB RX No No   Start Trial   Start Trial
Quagen PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040673-001 Mar 5, 2008 AB RX No No   Start Trial   Start Trial
Quagen ALBUTEROL SULFATE albuterol sulfate SYRUP;ORAL 212197-001 Sep 6, 2019 AA RX No No   Start Trial   Start Trial
Quagen PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 040673-003 Mar 5, 2008 AB RX No No   Start Trial   Start Trial
Quagen CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride SYRUP;ORAL 212423-001 May 22, 2019 AA RX No No   Start Trial   Start Trial
Quagen PROPYLTHIOURACIL propylthiouracil TABLET;ORAL 080154-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Colorcon
Johnson and Johnson
Merck
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.